gene

P2RY1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about P2RY1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

234Connections
1Hypotheses
4Analyses
50Outgoing
50Incoming

Summary

The P2RY1 gene encodes the P2Y1 purinergic receptor, a G protein-coupled receptor for ADP and ATP that plays important roles in platelet activation, neuroinflammation, and neurodegenerative disease pathogenesis.

View on Wiki →

🧬 Gene Info
Gene SymbolP2RY1
Full NamePurinergic Receptor P2Y1
Chromosome19
Protein FamilyP2Y receptor family (GPCR)
Protein TypeGpcr
Target ClassGpcr
FunctionGPCR antagonists or agonists modulating purinergic signaling
Mechanism of ActionGPCR antagonists or agonists modulating purinergic signaling
DruggabilityLow (0.41)
Clinical StagePhase I
Molecular Weight41 kDa
Exons2
PathwaysSpontaneous Bursting Activity
UniProt IDP47900
NCBI Gene ID5028
Ensembl IDENSG00000142203
OMIM181010
GeneCardsP2RY1
Human Protein AtlasP2RY1
Associated DiseasesALS, ALZHEIMER, Epilepsy, Focal Cortical Dysplasia, Hippocampal Sclerosis
Known Drugs/CompoundsMRS2500
InteractionsP2RX7, P2RX5, PANX1, ADORA2B, P2RX4, P2RX1
SciDEX TargetView Target Profile (2 clinical trials)
KG Connections234 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: P2RY1 — AlphaFold P47900 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

P2RY1 Gene

gene · 2543 words

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Therapeutics

index · 5665 words

Section 162: Advanced Antioxidant and Redox Therapy in CBS/PSP

therapeutic · 5600 words

coq10-neurodegeneration

therapeutic · 5142 words

Astrocyte Reactivity Mechanism

mechanism · 5036 words

Pathway Diagram

flowchart TD
    P2RY1["P2RY1<br/>Purinergic Receptor"]
    
    ADP["ADP<br/>Ligand"]
    P2RX7["P2RX7<br/>Ion Channel"]
    P2RX4["P2RX4<br/>Ion Channel"]
    PANX1["PANX1<br/>Pannexin Channel"]
    
    INFLAMMATION["Neuroinflammation<br/>Process"]
    MICROGLIA["Microglial<br/>Activation"]
    ATP_RELEASE["ATP Release<br/>Signaling"]
    
    ALS["Amyotrophic<br/>Lateral Sclerosis"]
    MS["Multiple<br/>Sclerosis"]
    NEURODEGENERATION["Neurodegeneration<br/>Pathology"]
    
    NEUROPROTECTION["Neuroprotective<br/>Effects"]
    THERAPEUTIC["Therapeutic<br/>Targeting"]
    
    ADP --|"activates"|--> P2RY1
    P2RY1 --|"interacts with"|--> P2RX7
    P2RY1 --|"activates"|--> PANX1
    P2RY1 --|"modulates"|--> P2RX4
    
    P2RY1 --|"activates"|--> INFLAMMATION
    INFLAMMATION --|"leads to"|--> MICROGLIA
    P2RX7 --|"promotes"|--> ATP_RELEASE
    PANX1 --|"facilitates"|--> ATP_RELEASE
    
    P2RY1 --|"dual role"|--> ALS
    P2RY1 --|"dual role"|--> MS
    ALS --|"contributes to"|--> NEURODEGENERATION
    MS --|"contributes to"|--> NEURODEGENERATION
    
    P2RY1 --|"can provide"|--> NEUROPROTECTION
    P2RY1 --|"potential"|--> THERAPEUTIC
    
    style P2RY1 fill:#006494
    style NEUROPROTECTION fill:#1b5e20
    style THERAPEUTIC fill:#1b5e20
    style INFLAMMATION fill:#ef5350
    style NEURODEGENERATION fill:#ef5350
    style ALS fill:#ef5350
    style MS fill:#ef5350
    style P2RX7 fill:#4a1a6b
    style PANX1 fill:#4a1a6b
    style ATP_RELEASE fill:#5d4400
    style MICROGLIA fill:#5d4400

Outgoing (159)

TargetRelationTypeStr
LUNG TISSUEexpressed_inentity0.95
UPREGULATESupregulatesentity0.95
IMMUNE CELLSexpressed_inentity0.90
THERAPEUTIC_TARGETtherapeutic_targetentity0.90
Lung Tissueexpressed_incell_type0.85

Incoming (75)

SourceRelationTypeStr
h-0758b337targetshypothesis0.80
P2RX7interacts_withgene0.66
P2RX7co_mentioned_withgene0.60
P2RX1therapeutic_targetgene0.60
P2RX4therapeutic_targetgene0.60

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TREM2-P2RY12 Balance Restoration Therapy 0.366 neurodegeneration Neuroinflammation and microglial priming

Mentioning Analyses (4)

Scientific analyses that reference this entity

What determines P2RY12 receptor expression/activity specifically in VSMCs during

neurodegeneration | 2026-04-07 | 0 hypotheses

How does P2RY12-mediated VSMC dysfunction contribute to cerebrovascular neurodeg

neurodegeneration | 2026-04-07 | 0 hypotheses

Neuroinflammation and microglial priming in early Alzheimer's Disease

neurodegeneration | 2026-04-04 | 0 hypotheses

Astrocyte reactivity subtypes in neurodegeneration

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.554

Related Papers (15)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei Neuron 2026 0
Role of TREM2 in neuroinflammation. [PMID:41213496] Abdulkhaliq AA, Alasiri G, Almoghrabi Y, Exp Neurol 2026 0
Targeting Itga8 Mitigates Neurogenic Bladder Fibrosis Driven by Trem2⁺ Macrophag [PMID:41355531] Wang J, Wang S, Ren L, Liu X, Zhang L et Adv Sci (Weinh) 2026 0
Hepatocyte Mettl3 Deficiency Drives Primary Sclerosing Cholangitis and Liver Fib [PMID:41431138] Pan W, Yong Y, Li Y, Shi G, Zhang M et a Adv Sci (Weinh) 2026 0
Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] Zhang J, St Pierre Schneider B, Muguerza Am J Physiol Endocrinol Metab 2026 0
Sulfatide deficiency-induced astrogliosis and myelin lipid dyshomeostasis are in [PMID:41513633] He S, Mittra N, Bao H, Bhattacharjee A, Nat Commun 2026 0
Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] Li X, Tang X, Zeng J, Duan L, Hou Z et a Cell 2026 0
TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] Feiten AF, Dahm K, Schlepckow K, van Len Nat Commun 2026 0
TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604] Yang HC, Deng YS, Zhang J, Zhang T, Song J Alzheimers Dis 2026 0
TREM2 in neurodegeneration and diseases. [PMID:41792456] ["Abdulkhaliq A", "Alasiri G", "Kim B", Molecular psychiatry 2026 0
Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] Aranda-Abreu GE, Rojas-Durán F, Hernánde Neurology international 2026 0
The microglial TREM2 receptor programs hippocampal development in a mouse model [PMID:41887542] Ahmed S, Bowers C, Munoz-Martin J, Jamwa Brain, behavior, and immunity 2026 0
Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] Alhusaini M, Mussa BM, Ilce BY, Alhaj H, Frontiers in aging neuroscienc 2026 0
Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268] ["Srivastav Jyotsna", "Sharma Sachin"] Frontiers in medicine 2025 0
Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. [PMID:20301376] Adam MP, Bick S, Mirzaa GM, Pagon RA, Wa 1993 0